Cryo-Cell International, Inc. (CCEL)
 NYSEAMERICAN: CCEL · Real-Time Price · USD
 4.530
 +0.040 (0.89%)
  Oct 31, 2025, 12:45 PM EDT - Market open
Cryo-Cell International Revenue
Cryo-Cell International had revenue of $7.83M in the quarter ending August 31, 2025, a decrease of -2.99%. This brings the company's revenue in the last twelve months to $31.75M, down -0.29% year-over-year. In the fiscal year ending November 30, 2024, Cryo-Cell International had annual revenue of $31.99M with 2.05% growth.
Revenue (ttm) 
 $31.75M
Revenue Growth 
 -0.29%
P/S Ratio 
 1.14
Revenue / Employee 
 $369,157
Employees 
 86
Market Cap 
36.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Nov 30, 2024 | 31.99M | 642.41K | 2.05% | 
| Nov 30, 2023 | 31.34M | 1.01M | 3.32% | 
| Nov 30, 2022 | 30.34M | 1.45M | 5.03% | 
| Nov 30, 2021 | 28.88M | -2.26M | -7.26% | 
| Nov 30, 2020 | 31.15M | -668.98K | -2.10% | 
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| Eli Lilly and Company | 59.42B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
CCEL News
- 15 days ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results - Business Wire
- 2 months ago - Cryo-Cell International, Inc. Provides Dividend Update - Business Wire
- 3 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results - Business Wire
- 6 months ago - Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend - Business Wire
- 8 months ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024 - Business Wire
- 9 months ago - Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results - Business Wire